Chapter 26. Hepatocellular Carcinoma

  1. Pierre-Alain Clavien MD, Phd, FACS, FRCS Professor Chairman and
  2. Stefan Breitenstein MD
  1. Tadatoshi Takayama MD, PhD Professor of Surgery

Published Online: 9 DEC 2009

DOI: 10.1002/9781444317053.ch26

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

How to Cite

Takayama, T. (2010) Hepatocellular Carcinoma, in Malignant Liver Tumors: Current and Emerging Therapies, Third Edition (eds P.-A. Clavien and S. Breitenstein), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444317053.ch26

Editor Information

  1. Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland

Author Information

  1. Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan

Publication History

  1. Published Online: 9 DEC 2009
  2. Published Print: 12 JAN 2010

ISBN Information

Print ISBN: 9781405179768

Online ISBN: 9781444317053

SEARCH

Keywords:

  • Hepatocellular Carcinoma;
  • transarterial chemoembolization (TACE);
  • The Cancer of the Liver Italian Program (CLIP);
  • Discrepancies between the Western and the Eastern guidelines;
  • “Degree of liver damage”;
  • Western guidelines;
  • The Barcelona Clinic Liver Cancer (BCLC);
  • The Cancer of the Liver Italian Program (CLIP)

Summary

This chapter contains sections titled:

  • Introduction

  • Staging systems

  • Treatment guidelines

  • Conclusion

  • References

  • Self-assessment questions

  • Self-assessment answers